Catalogo dei prodotti della ricerca

BERSANI, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.626
NA - Nord America 8.461
AS - Asia 1.793
SA - Sud America 200
OC - Oceania 74
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.216
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.327
IT - Italia 6.361
IN - India 742
UA - Ucraina 626
SG - Singapore 597
FI - Finlandia 378
SE - Svezia 314
FR - Francia 229
CN - Cina 215
GB - Regno Unito 213
AR - Argentina 159
DE - Germania 149
CA - Canada 112
TR - Turchia 89
AU - Australia 64
IE - Irlanda 63
CH - Svizzera 48
BG - Bulgaria 34
PK - Pakistan 32
RO - Romania 31
NL - Olanda 30
ES - Italia 27
MY - Malesia 25
PH - Filippine 23
BR - Brasile 22
PL - Polonia 20
ZA - Sudafrica 20
EG - Egitto 18
IR - Iran 17
BE - Belgio 16
MX - Messico 15
CZ - Repubblica Ceca 14
JP - Giappone 14
RU - Federazione Russa 12
CL - Cile 11
TW - Taiwan 11
NZ - Nuova Zelanda 10
TG - Togo 9
GR - Grecia 7
ID - Indonesia 7
SV - El Salvador 7
AL - Albania 6
AT - Austria 6
HR - Croazia 6
CO - Colombia 5
DK - Danimarca 5
NG - Nigeria 5
PT - Portogallo 5
IL - Israele 4
KR - Corea 4
LT - Lituania 4
MD - Moldavia 4
MT - Malta 4
EU - Europa 3
KE - Kenya 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
EC - Ecuador 2
GH - Ghana 2
HK - Hong Kong 2
LU - Lussemburgo 2
NP - Nepal 2
SI - Slovenia 2
SM - San Marino 2
TH - Thailandia 2
VN - Vietnam 2
BD - Bangladesh 1
HU - Ungheria 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
PE - Perù 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
TN - Tunisia 1
Totale 19.216
Salva come PNG Salva come JPEG
Città #
Fairfield 959
Chandler 627
Woodbridge 554
Rome 519
Milan 449
Ann Arbor 432
Houston 423
Ashburn 414
Princeton 390
Plano 363
Singapore 361
Wilmington 356
San Paolo di Civitate 316
Seattle 311
Boston 304
Cambridge 281
Jacksonville 183
Lawrence 183
Beijing 162
Federal 149
Millbury 117
San Diego 113
Andover 111
Des Moines 94
Norwalk 84
Catania 82
Toronto 75
Florence 66
Naples 63
Falls Church 62
Boardman 58
Dublin 57
Palermo 50
Turin 50
Bari 47
New York 44
Bologna 39
San Mateo 38
Dallas 34
Padova 34
Helsinki 31
Istanbul 31
Torino 30
Verona 30
Napoli 29
Santa Clara 27
Como 25
Southend 24
Bühl 23
London 22
Ankara 21
Messina 21
Mannheim 20
Pisa 20
Bergamo 19
Brisbane 18
Mumbai 17
Mountain View 16
Perugia 16
San Antonio 16
Sandy 16
Sofia 16
Dearborn 14
Pescara 14
Buffalo 13
Lahore 13
La Spezia 12
Latina 12
Macerata 12
Monza 12
Nardò 12
Perth 12
Pune 12
Treviso 12
Brussels 11
Burgas 11
Caserta 11
Corato 11
Falkenstein 11
Karachi 11
Parma 11
Pflugerville 11
Phoenix 11
Redwood City 11
Salerno 11
Vicenza 11
Avellino 10
Brescia 10
Cagliari 10
Corsico 10
Lecce 10
Livorno 10
Ottawa 10
Paris 10
Redmond 10
Reggio Calabria 10
Sydney 10
Zurich 10
Frosinone 9
Genoa 9
Totale 9.962
Salva come PNG Salva come JPEG
Nome #
La calcificazione della ghiandola pineale e dei plessi corioidei nella schizofrenia: uno studio mediante TAC 5.330
Night Eating Syndrome, circadian rhythms and seasonality. A study in a population of Italian university students 287
Nootropics use in the workplace. Psychiatric and ethical aftermath towards the new frontier of bioengineering 284
Sintomi neurologici associati a sintomi psichiatrici in un caso di cisti aracnoidea 170
Hooked on the mirror: the emergence of exercise addiction, body dysmorphic disorder, and other image-related psychopathological correlates in fitness settings 123
Aspetti descrittivi, demografici e clinici di un campione di pazienti con disturbo dell'adattamento 113
Deep Transcranial Magnetic Stimulation for treatment-resistant bipolar depression: A case report of acute and maintenance efficacy 110
Ultradian variation of nerve growth factor plasma levels in healthy and schizophrenic subjects 107
5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with Ritanserin 102
Studio in doppio cieco della terapia ambulatoriale della Schizofrenia con Trifluperazina versus decanoato di Flufenazina 97
L'adattamento premorboso negli schizofrenici: variabili biologiche, ambientali e caratteriali 97
L acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine 94
Cerebral ventricular enlargement and neuroleptic response in chronic schizophrenia: preliminary findings with risperidone 94
25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug 86
An association study between schizophrenia and the dopamine receptor genes DRD3 and DRD4 using haplotype relative risk 85
Association of schizophrenia and Carpenter syndrome 85
Exploring the relationship between mental wellbeing, exercise routines and the intake of Image and Performance Enhancing Drugs during the COVID-19 pandemic. A comparison across sport disciplines 85
Antidepressant effectiveness of deep Transcranial Magnetic Stimulation (dTMS) in patients with Major Depressive Disorder (MDD) with or without Alcohol Use Disorders (AUDs): A 6-month, open label, follow-up study 84
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. 81
Potential neuroprotective effect of lithium in bipolar patients evaluated by neuropsychological assessment. Preliminary results 81
Cannabis use related to early psychotic onset. Role of premorbid function 80
A double-blind comparative study of Sertraline and Amitriptyline in outpatients with Major Depressive Episodes 79
Choroid plexus calcification as a possible clue of serotonin implication in schizophrenia 79
The emergence of exercise addiction, body dysmorphic disorder, and other image-related psychopathological correlates in fitness settings. A cross sectional study 79
Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes 76
Effects of treatment with etizolam 0.5 mg BID on cognitive performance: A 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder 76
Studio in doppio cieco della Flufenazina decanoato versus placebo nella terapia ambulatoriale di mantenimento di pazienti schizofrenici cronici 75
Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review 75
ETHOLOGICAL PREDICTORS OF AMITRIPTYLINE RESPONSE IN DEPRESSED OUTPATIENTS 75
New perspectives on techniques for the clinical psychiatrist: Brain stimulation, chronobiology and psychiatric brain imaging 74
Combined Serotonin 5-HT2 and Dopamine D2 antagonism in Schizophrenia: clinical, extrapyramidal and neuroendocrine response in a preliminary study with Risperidone (R 64766) 74
Facial expression in patients with bipolar disorder and schizophrenia in response to emotional stimuli: a partially shared cognitive and social deficit of the two disorders. 73
Demographic variables, clinical aspects, and medicolegal implications in a population of patients with adjustment disorder 72
Captagon. Use and trade in the Middle East 72
5-HT2 antagonist Ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with Orphenadrine and placebo 72
Corticotropin-releasing factor and adrenal function in major depression 70
Anomalie di G-6-PD in due soggetti con disturbo schizoide di personalità 70
Influence of obstetric complication severity on brain morphology in schizophrenia: an MR study 69
Immediate Serum Growth Hormone Decrease as a Potential Index of Dopamine-Related Response to Electroconvulsive Therapy in Schizophrenic Patients 69
Levetiracetam in bipolar spectrum disorders: first evidence of efficacy in an open, add-on study 69
Reduced natural killer cell activity in major depression: neuroendocrine implications 68
Novel psychoactive substances (NPS) use in severe mental illness (SMI) patients. Potential changes in the phenomenology of psychiatric diseases 68
Adjustment disorders: medico-legal implications in the assessment of biological damage 68
Excess in the spring and deficit in the autumn in birth rates of male schizophrenic patients in Italy: Potential role of perinatal risk factors 67
Olanzapine as the ideal "trip terminator"? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms 67
Severity of obstetric complications and risk of adult schizophrenia in male patients: a case-control study 67
Negative symptoms and visual behavior in DSM III-R prognostic subtypes schizophreniform disorder 66
Reduction of night/day difference in melatonin blood levels as possible disease-related index in schizophrenia 66
The HLA System as a genetic marker of affective disorders: reports on a population from central Italy, with comments on methodology 65
Neurological soft signs discriminate schizophrenia from bipolar disorder. 65
Deficit of executive functions in schizophrenia: Relationship to neurological soft signs and psychopathology 64
Computed tomography study of pineal calcification in schizophrenia 63
Obstetric complications and neurological soft signs in male patients with schizophrenia 63
Atypical antipsychotics and polydipsia: a cause or a treatment? 62
Serotonina e depressione: studio multicentrico controllato Tianeptina versus Amitriptilina 62
Pilot study on light therapy and neurocognitive performance of attention and memory in healthy subjects 62
The prolactin response in patients receiving neuroleptic therapy. The effect of Fluphenazine decanoate 62
Premorbid sleep, appetite, energy, and cognitive circadian profile in patients with depressive disorders 61
Neurological soft signs and cerebral measurements investigated by means of MRI in schizophrenic patients 61
"Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web. 61
Comparison of facial expression in patients with obsessive-compulsive disorder and schizophrenia using the facial action coding system: a preliminary study 61
Melatonin add-on in manic patients with treatment resistant insomnia 59
Facial action coding system (facs): uno strumento di valutazione obiettiva dell’espressività mimica facciale e le sue potenziali applicazioni allo studio della schizofrenia 59
Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders 58
Hair analysis for the detection of drug use-is there potential for evasion? 58
Schizophrenia and neurogenesis. A stem cell approach 57
Exploring the use of Kratom (Mitragyna speciosa) via the YouTube data tool: A novel netnographic analysis 57
Mood disorder in a patient with Smith-Magenis syndrome: A case report 55
Disturbo dell'umore e disturbo esplosivo intermittente in un paziente con sindrome di Smith-Magenis: un caso clinico 55
HLA antigens and neuroleptic response in clinical subtypes of schizophrenia 55
Decision making in mild cognitive impairment: medicolegal implications 55
Manic-like psychosis associated with elevated trough tacrolimus blood concentrations 17 years after kidney transplant. 54
Changes in dream experience in relation with antidepressant escitalopram treatment in depressed female patients: A preliminary study 54
Corpus callosum abnormalities and potential age effect in male schizophrenics: an MRI comparative study 53
Sertraline in the treatment of major depression: an open clinical stratification study in Italian outpatients 53
Studio naturalistico sull'impiego degli antipsicotici nella formulazione long acting negli SPDC di Roma e del Lazio 52
Anamnesi di comportamento aggressivo in pazienti psichiatrici: ruolo di variabili sociodemografiche, familiari, cliniche e cronobiologiche 52
La genetica nei disturbi mentali 52
Il PANDAS come possibile modello interpretativo del meccanismo patogenetico del DOC nell'adulto 52
The potential role of high or low birthweight as risk factor for adult schizophrenia 51
Brain abnormalities in schizophrenia. A qualitative comparative study of schizophrenic patients and control individuals assessed by magnetic resonance imaging. 51
Risk of schizophrenia in male subjects with a history of obstetric complications and their siblings: A controlled study. 51
Generalized and specific emotion impairments as potential markers of severity in obsessive-compulsive disorder. A preliminary study using Facial Action Coding System (FACS) 50
La legalizzazione della cannabis. Tra irresponsabilità politica e deresponsabilizzazione degli psichiatri 50
Lithium from mood stabilizer to putative cognitive enhancer 50
Can mobile phone technology support a rapid sharing of information on novel psychoactive substances among health and other professionals internationally? 50
Manifesto for a European research network into obsessive-compulsive and related disorders. 50
Associazione di epilessia e schizofrenia: studio descrittivo di un campione di pazienti indagato con risonanza magnetica nucleare (RMN) ed elettroencefalografia standard (EEG) 49
Neurological Soft Signs in schizophrenic patients treated with conventional and atypical antipsychotics 49
Olfactory identification deficits and associated response inhibition in obsessive-compulsive disorder: On the scent of the orbitofronto-striatal model 48
Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders 48
Negative symptoms as key features of depression among cannabis users: a preliminary report. 48
Dissociative symptoms in female patients with mood and anxiety disorders: a psychopathological and temperamental investigation. 47
Valutazioni morfofunzionali cerebrali e trattamento farmacologico in un caso clinico di schizofrenia con polidipsia 46
Changes in impulse control disorder features in a present kleptomania patient and importance of rational treatment strategy on social dangerousness. a case report 46
Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psycopathology 46
Riso e depressione: ipotesi di rapporto patogenetico e terapeutico 44
Neurological Soft Signs and Corpus Callosum morphology in schizophrenia 44
Can kratom (Mitragyna speciosa) alleviate COVID-19 pain? A case study 44
L’incerto confine diagnostico tra Disturbo Psicotico ed Ossessivo-compulsivo nell’esame di quattro casi clinici 44
Totale 12.418
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 400
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.643
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.819 0 0 0 156 188 211 220 275 203 249 163 154
2020/20211.683 154 160 129 157 105 98 105 170 147 243 146 69
2021/20223.900 86 293 322 246 476 91 94 416 361 354 343 818
2022/20233.576 721 668 191 232 366 379 111 245 290 111 168 94
2023/20242.860 194 275 161 255 200 211 112 151 62 430 382 427
2024/2025821 308 164 298 51 0 0 0 0 0 0 0 0
Totale 19.577